U.S. Department of Health & Human Services Divider Arrow National Institutes of Health Divider Arrow NCATS

Approval Year

Unknown
149124
Name Type Language
MESMULOGENE ANCOVACIVEC
INN  
Official Name English
TG-4010
Preferred Name English
TG 4010 [WHO-DD]
Common Name English
mesmulogene ancovacivec [INN]
Common Name English
MVA-MUC1-IL2 (MESMULOGENE ANCOVACIVEC)
Common Name English
AN ANTITUMOR VACCINE CONTAINING A RECOMBINANT MODIFIED VIRUS ANKARA EXPRESSING INTERLEUKIN 2 AND THE TUMOR-ASSOCIATED ANTIGEN MUC1
Common Name English
TG4010
Code English
Code System Code Type Description
NCI_THESAURUS
C2241
Created by admin on Wed Apr 02 11:06:12 GMT 2025 , Edited by admin on Wed Apr 02 11:06:12 GMT 2025
PRIMARY
FDA UNII
WQQ9XZH2CC
Created by admin on Wed Apr 02 11:06:12 GMT 2025 , Edited by admin on Wed Apr 02 11:06:12 GMT 2025
PRIMARY
SMS_ID
100000175848
Created by admin on Wed Apr 02 11:06:12 GMT 2025 , Edited by admin on Wed Apr 02 11:06:12 GMT 2025
PRIMARY
CAS
1246525-59-6
Created by admin on Wed Apr 02 11:06:12 GMT 2025 , Edited by admin on Wed Apr 02 11:06:12 GMT 2025
PRIMARY
INN
10254
Created by admin on Wed Apr 02 11:06:12 GMT 2025 , Edited by admin on Wed Apr 02 11:06:12 GMT 2025
PRIMARY
NIH
NCATS
PRIVACY NOTICE
ACCESSIBILITY
DISCLAIMER
HHS VULNERABILITY DISCLOSURE
For language access assistance, contact the NCATS Public Information Officer
National Center for Advancing Translational Sciences (NCATS),
6701 Democracy Boulevard, Bethesda MD 20892-4874 • 301-594-8966